Agilent 1100 Series Automated Identification of Buspirone Metabolites Application Note

About this manual

The document details a systematic approach for identifying drug metabolites, specifically focusing on buspirone. It utilizes an incubation strategy with rat liver S9 fractions followed by analysis via capillary liquid chromatography (LC) coupled with two complementary mass spectrometric techniques: the Agilent MSD Trap XCT ion trap and the LC/MSD TOF.

The study highlights the use of automated data-dependent acquisition in the ion trap MS to detect unexpected metabolites co-eluting with major peaks. By combining this with accurate mass measurements from the ESI oaTOF instrument, the authors postulated structures for five previously unreported metabolites using ACD/Labs software tools.

What's inside

• Abstract
• Introduction
• Experimental
• Metabolite Identification Strategy
• Equipment and Conditions
• ACD/Labs Software Analysis
• Results and Discussion

Frequently asked questions

What temperature and duration were used for the buspirone incubation?

The reaction was carried out at 37° C for 60 minutes.

What is the flow rate used during chromatographic analysis?

The flow rate was set to 4 L/min.

How many precursor ions were selected for MS/MS data acquisition?

The analysis selected a number of three precursors.